Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;102(5):1324-30.
doi: 10.1016/j.fertnstert.2014.07.1234. Epub 2014 Sep 11.

Female cystic fibrosis mutation carriers and assisted reproductive technology: does carrier status affect reproductive outcomes?

Affiliations
Free article

Female cystic fibrosis mutation carriers and assisted reproductive technology: does carrier status affect reproductive outcomes?

Teresa A VanWort et al. Fertil Steril. 2014 Nov.
Free article

Abstract

Objective: To evaluate the association between female cystic fibrosis (CF) carrier status and in vitro fertilization (IVF) response and outcomes. The presence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in male carriers has been associated with infertility, yet possible adverse effects on the ovarian function and reproductive outcomes of female carriers have not been studied to date.

Design: Retrospective cohort study.

Setting: Private academic, clinical reproductive center.

Patient(s): Females<40 years of age who were screened for CFTR mutations and received IVF treatment between July 2002 and March 2013.

Intervention(s): Patients initiated controlled ovarian hyperstimulation with frequent monitoring, vaginal oocyte retrieval, fertilization, embryo transfer, and a pregnancy test. Various measures of IVF stimulation response and cycle outcome were evaluated for both carriers and noncarriers.

Main outcome measure(s): Analysis was performed by logistic regression and Poisson regression.

Result(s): IVF cycles (n=199) from CFTR mutation carrier patients (n=112) were analyzed. No significant differences in outcome were noted when carriers of different mutation loci were compared in aggregate with the noncarrier group (n=6,420 cycles from 3,555 patients). Significant differences were noted for some metrics when the carriers were grouped by mutation loci.

Conclusion(s): Overall, no significant differences in stimulation response and cycle outcome were noted between female CFTR mutation carriers and noncarriers. Further research is needed to investigate whether the differences noted between specific CFTR mutation loci are clinically relevant and whether CFTR mutations may impact reproductive outcomes outside the context of assisted reproductive technologies.

Keywords: Cystic fibrosis; female fertility; heterozygote; in vitro fertilization; ovarian function.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources